ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

Congress Presentation

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)
39 presentations
7 followers

6 more presentations in this session

Nationwide trends in stroke and atrial fibrillation in patients with incident type 2 diabetes

Speaker: Doctor C. Gyldenkerne (Aarhus, DK)

Thumbnail

CRISP-CT: Incorporating FAI-Score In Clinical Decision Making

Speaker: Professor C. Antoniades (Oxford, GB)

Thumbnail

Opiates and its effects on cardiovascular outcomes

Speaker: Doctor S. Liew (Melbourne, AU)

Thumbnail

E3 Trial: The 52-Week Results

Speaker: Doctor K. Filion (Montreal, CA)

Thumbnail

Long term effects of the Randomized Evaluation of Secondary Prevention by Outpatient Nurse Specialists-2 trial (RESPONSE-2)

Speaker: Doctor H. Jorstad (Amsterdam, NL)

Thumbnail

Access the full session

Latest Science in CV Prevention

Speakers: Professor D. Bhatt, Doctor C. Gyldenkerne, Professor C. Antoniades, Doctor S. Liew, Doctor K. Filion...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb